共 256 条
- [1] Ference BA(2017)Low-density lipoproteins cause atherosclerotic cardiovascular disease 1 Evidence from genetic, epidemiologic, and clinical studies A consensus statement from the European Atherosclerosis Society Consensus Panel Eur Heart J. 38 2459-72
- [2] Ginsberg HN(2016)Cardiovascular disease in Europe: epidemiological update 2016 Eur Heart J 37 3232-3245
- [3] Graham I(2019)ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk Atherosclerosis 2019 140-205
- [4] Ray KK(2010)Lipoprotein(a) as a cardiovascular risk factor: current status Eur Heart J 31 2844-2853
- [5] Packard CJ(2016)Structure, function, and genetics of lipoprotein (a) J Lipid Res 57 1339-1359
- [6] Bruckert E(2013)Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society Eur Heart J 34 3478-3490
- [7] Townsend N(2017)Lipoprotein(a): the revenant Eur Heart J 38 1553-1560
- [8] Wilson L(2018)The role of lipoprotein (a) in chronic kidney disease J Lipid Res 59 577-585
- [9] Bhatnagar P(2018)Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials Lancet 392 1311-1320
- [10] Wickramasinghe K(2020)Lipoprotein(a) and PCSK9 inhibition: clinical evidence Eur Heart J Suppl 22 L53-L56